Lycopene and beta-carotene induce growth inhibition and proapoptotic effects on ACTH-secreting pituitary adenoma

Natália F Haddad1, Anderson J Teodoro, Felipe Leite de Oliveira

  • 1Instituto de Ciências Biomédicas, Universidade Federal do Rio de Janeiro, Brazil.

Plos One
|May 14, 2013
PubMed

Insights

Beta-carotene and lycopene, found in functional foods, reduce pituitary adenoma cell viability and ACTH secretion. These carotenoids may offer a new treatment for Cushing

Area of Science:

  • Endocrinology
  • Cell Biology
  • Nutritional Science

Background:

  • Pituitary adenomas cause significant morbidity due to hormonal imbalances and tumor compression.
  • Carotenoids, found in functional foods, are known for their potential to mitigate chronic diseases.
  • Understanding carotenoid effects on pituitary adenoma cells is crucial for developing novel therapeutic strategies.

Purpose of the Study:

  • To investigate the impact of beta-carotene and lycopene on ACTH-secreting pituitary adenoma cells (AtT20).
  • To assess the effects on cell viability, proliferation, cell cycle, apoptosis, and hormone secretion.
  • To explore the influence on intercellular communication and specific protein expression (connexin 43, Skp2, p27(kip1)).

Main Methods:

  • AtT20 cells were treated with varying concentrations of beta-carotene and lycopene for 48 and 96 hours.
  • Assays included cell viability, colony formation, cell cycle analysis, apoptosis detection, and ACTH secretion measurement.
  • Intercellular communication, connexin 43 phosphorylation, and expression of Skp2 and p27(kip1) were evaluated.

Main Results:

  • Both beta-carotene and lycopene decreased AtT20 cell viability and colony formation.
  • Carotenoids induced apoptosis and altered cell cycle progression in a dose-dependent manner.
  • ACTH secretion was reduced, intercellular communication was inhibited, and connexin 43 phosphorylation increased, alongside changes in Skp2 and p27(kip1) expression.

Conclusions:

  • Lycopene and beta-carotene demonstrate potential in negatively modulating the malignant phenotype of pituitary adenoma cells.
  • The observed effects may involve alterations in connexin 43, Skp2, and p27(kip1) expression.
  • These carotenoids suggest a potential novel pharmacological approach for treating Cushing's disease.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of cells.
Two...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...